Document is current
Any future updates will be listed below
-
Authors
Phillips, Richard https://orcid.org/0000-0002-8978-9743
Basu, Bristi https://orcid.org/0000-0002-3562-2868
Butt, Zohra
Beloueche, Mounia
Cook, Natalie https://orcid.org/0000-0003-2606-1082
Crabb, Simon J. https://orcid.org/0000-0003-3521-9064
Greystoke, Alastair https://orcid.org/0000-0001-9168-0387
Hargrave, Darren
Jones, Robert
Kureeman, Muhammad Yasin
Lopez, Juanita https://orcid.org/0000-0001-8321-4212
McKeeve, Claire
Meissner, Magdalena https://orcid.org/0000-0001-5897-0219
O’Carrigan, Brent https://orcid.org/0000-0001-8187-6298
Parkes, Eileen E. https://orcid.org/0000-0002-7855-3698
Ronghe, Milind
Roxburgh, Patricia https://orcid.org/0000-0001-9869-591X
Sarker, Debashis https://orcid.org/0000-0003-4814-8429
Savage, Kienan I. https://orcid.org/0000-0002-4898-899X
Shaw, Paul H. S.
Symeonides, Stefan https://orcid.org/0000-0002-9892-9314
Tweddle, Deborah A.
Vedi, Aditi https://orcid.org/0000-0001-6761-6510
Walter, Harriet S. https://orcid.org/0000-0003-2618-711X
Zabkiewicz, Joanna
Middleton, Gary W. https://orcid.org/0000-0001-5695-3474
Beggs, Andrew D. https://orcid.org/0000-0003-0784-2967
- License Information
-
More Information
Article History
Received: 18 June 2025
Revised: 29 September 2025
Accepted: 23 October 2025
First Online: 8 November 2025
Ethics approval and consent to participate
: Formal ethics approval was not required for this study, as it did not constitute research involving human participants under UK research ethics frameworks. The Delphi survey sought expert opinion from academic professionals acting in their official capacity. No personal, sensitive, or identifiable data were collected or analysed. Participation was voluntary, with the option to withdraw at any stage. The study presented no foreseeable risk and involved professional judgment only. In accordance with the UK ESRC Framework for Research Ethics and institutional policies, the work falls outside the remit of formal ethical review. All procedures nevertheless adhered to principles of research integrity, including informed consent, confidentiality, and respect for participant autonomy and expertise.
: SJC has received personal fees for speaking and/or advisory work from Amgen, Amphista Therapeutics, Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Duality Bio, Ipsen, Janssen, Merck, MSD, Novartis, Pfizer, Veracyte and Roche. He has also received research funding support for clinical trials from Astex Pharmaceuticals, AstraZeneca, Clovis Oncology and Roche. AG has received personal fees for advisory boards from Foundation Medicine and Guardant NC has received consulting fees from Roche Pharmaceuticals, Servier and REDX Pharmaceuticals; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Roche Pharmaceuticals; support for attending meetings and/or travel from Roche Pharmaceuticals; research funding to research team from AstraZeneca, Orion, F. Hoffmann-La Roche Ltd, Taiho, Novartis, Starpharma, Bayer, Eisai, UCB, RedX Pharmaceuticals, LOXO-oncology, Avacta, Boehringer Ingelheim, Merck and Tarveda Therapeutics; participated in data safety monitoring board or advisory board at Roche Pharmaceuticals and Cancer Research UK. BO’C has been speaker honoraria for BMS, MSD, Ipsen. DH has received fees from Alexion/ AstraZeneca, Day One Biotherapeutic, Ipsen, Novartis PHSS has held advisory role AZ, BI, BioNtech and Takedo. Educational support Roche. DS has received consultancy or honoraria fees from Servier, Pfizer, Ipsen, Bayer, MSD, Roche, Servier, AstraZeneca, Boehringer, AbbVie, Sirtex, AAA, Incyte, and Eisai. EEP has served on advisory boards and received fees from companies including Boehringer Ingelheim, Curadev, InhaTarget, Theolytics and AkamisBio. She is an employee of the University of Oxford which has received funding or other support for research work from AstraZeneca and STIpe Therapeutics.
